Background: Platelet-derived growth factor (PDGF) promotes cell-cycle progression by engaging signaling enzymes such as phospholipase Cγ (PLCγ). When activated, PLCγ cleaves phosphatidylinositol-4,5-bisphosphate to produce inositol-1,4,5-trisphosphate (IP 3 ) and diacylglycerol (DAG). IP 3 stimulates the release of calcium from intracellular stores, which together with DAG activate some protein kinase C (PKC) family members. In this study we focused on putative downstream effectors of PLCγ − PKC family members. We investigated whether, and when, DAG-responsive PKCs contribute to PDGFdependent DNA synthesis.
Background
In order to progress into S phase, serum-starved cells require continual exposure to growth factor for about 8-12 hours [1] . This raises the possibility that growth factors initiate signaling events beyond the commonly studied early time points (0-60 minutes). Indeed, microinjection of reagents that block Ras or phosphoinositide 3-kinase (PI 3-kinase) inhibit entry into S phase even when the injection is performed 4-6 hours after addition of growth factor [2, 3] . Direct evidence that growth factors induce signaling events beyond the 60 minute interval includes the finding that Ras and PI 3-kinase are activated 4 or more hours after stimulation [4, 5] . These data show that growth factors initiate signaling events even after the early time points, and these late events play a key role in the transition into S phase.
In multiple cell systems, phospholipase Cγ (PLCγ) plays a role in platelet-derived growth factor (PDGF)-dependent DNA synthesis [6, 7] , suggesting that the members of the protein kinase C (PKC) family that are responsive to DAG contribute to mitogenic signaling. Recent work by Wang et al. [8] showed that DAG was able to rescue DNA synthesis dependent on epidermal growth factor or plateletderived growth factor (PDGF) when this response was blocked by injection of a combination of the Src homology domains (SH2-SH2-SH3) of PLCγ. These experiments indicate that DAG-responsive PKC family members are downstream of PLCγ in the mitogenic cascade initiated by growth factors; the time at which DAG is required for DNA synthesis has not been determined, however.
The PKCs are a large family of serine/threonine kinases that includes at least 11 members. On the basis of their structure and biochemical properties, they can be divided into three groups: conventional PKC (cPKCs) α, βI, βII and γ; novel PKC (nPKCs) δ, ε, η, θ and µ; and atypical PKC (aPKCs) ζ and γ. The activity of all PKC family members depends on phosphatidylserine, but requires different activators [9, 10] . The cPKCs are activated in a DAG-and calcium-dependent manner; nPKC activity is DAG-dependent but calcium-independent [9, 10] ; aPKCs do not respond to DAG or calcium, but are activated by other lipids, such as phosphatidylinositol-3,4,5-triphosphate (PtdIns-3,4,5-P 3 ) [11, 12] . At least one novel PKC subfamily member PKCε is activated by both DAG and PI 3-kinase lipid product PtdIns-3,4,5-P 3 [10] . This suggests that PKCε may be an integrator of PLCγ and PI 3-kinase mitogenic signaling pathways.
Here, we investigated whether, and when, DAG-responsive PKCs contribute to PDGF-dependent DNA synthesis. We focused on DAG-dependent PKCs and found that they were activated early and then later (4-9 hours) in PDGF-stimulated cells. We also find that the later phase of PKCs activity was required for entry into S phase. In addition, DAG-dependent PKCs were not essential for the PI 3-kinase-dependent mitogenic signaling, even though at least one PKC in this group (PKCε) was activated by the PI 3-kinase-dependent pathway.
Results

DAG rescues PDGF-dependent DNA synthesis in cells expressing the F5 β βPDGFRs
In the experiments described here, we used HepG2 cells expressing wild type, Y40/51 or F5 PDGF β receptors (βPDGFRs). The F5 mutant receptor is unable to recruit PI 3-kinase, Ras GTPase activating protein, the protein tyrosine phosphatase SHP-2, and PLCγ, and in multiple cell types fails to initiate DNA synthesis [7] . The Y40/51 βPDGFR has restored binding sites for PI 3-kinase (tyrosines 740 and 751). In this system, restoration of tyrosines required for association of PI 3-kinase or PLCγ rescued the majority of the DNA synthesis response, indicating that PI 3-kinase and PLCγ play an important role in PDGF-dependent mitogenic signaling [7] .
We tested whether and when exogenously added DAG rescues PDGF-dependent DNA synthesis in HepG2 cells expressing F5 βPDGFRs. As shown in Figure 1a , addition of only PDGF or DAG did not stimulate DNA synthesis. DNA synthesis was induced by addition of both PDGF and DAG, provided that the DAG was added 6-7 hours after PDGF. Adding the DAG at earlier or later times was less effective or completely ineffective ( Figure 1a and data not shown). DAG alone failed to induce the DNAsynthesis response, regardless of when it was added. These findings suggest that DAG contributes to PDGFdependent cell cycle progression, and that the critical time of action is 6-7 hours after PDGF stimulation. The reason why the late requirement for DAG is not satisfied by early addition of DAG may be due to the rapid metabolism of DAG. We found that when the dose of DAG was increased to 200 µg/ml, it rescued PDGF-dependent DNA synthesis even when DAG was added simultaneously with PDGF (data not shown).
If DAG is making a contribution to PDGF-dependent cell cycle progression at 6-7 hours post PDGF, then its levels should be elevated at this time point. To test this hypothesis, we determined when PDGF triggers an accumulation of DAG in HepG2 cells expressing wild-type βPDGFRs. As shown in Figure 1b , PDGF triggered an increase in the cellular level of DAG, which remained elevated for at least 7 hours. The decrease at the 2 hours time point was a reproducible trend. These results show that PDGF triggered a prolonged increase in the cellular level of DAG. Importantly, DAG was elevated at the times when exogenously-added DAG rescued PDGF-dependent DNA synthesis. The earlier increase in DAG may be required for PDGF-stimulated events other than DNA synthesis. PDGF increases the level of DAG, which contributes to PDGF-dependent DNA synthesis. (a) DAG rescues PDGF-dependent DNA synthesis. Quiescent HepG2 cells expressing F5 βPDGFRs were exposed to 10% FBS, 50 ng/ml PDGF or buffer (left panel). In the right panel cells were stimulated with 50 ng/ml PDGF, and 100 µg/ml DAG was added to the cells either simultaneously with PDGF or 7 h later. Alternatively, the cells were treated with 100 µg/ml DAG alone. After 18 h, the cells were pulsed with 
PDGF activates PKCs at two distinct time points
DAG is a potent physiological activator of some PKC family members. HepG2 cells express at least four isoforms of the PKC family [13] and three of them, PKCα, PKCβII and PKCε, are activated by DAG. We focused on the kinetics of PDGF-dependent PKCε activity, because activation of PKCε requires DAG and is calcium-independent. Figure 2a shows that PDGF increased PKCε activity at two distinct time points, 10 minutes after PDGF stimulation and then 5-9 hours later. The first phase of PKCε activity was transient, whereas the second phase of activity was sustained. PKCε activity in HepG2 cells expressing F5 βPDGFRs was also investigated. Unlike the wild-type βPDGFR, the F5 receptor failed to activate PKCε at all time points tested ( Figure 2b ).
As PKCε can be activated by PtdIns-3,4,5-P 3 [12] , it may be contributing to activation of PKCε at late time points. In fact, PtdIns-3,4,5-P 3 levels are elevated 3-7 hours after PDGF stimulation in HepG2 cells [4] . To test whether there was a requirement for PI 3-kinase in PDGF-dependent activation of PKCε, we determined whether blocking PI 3-kinase activity would attenuate PKCε activation. As shown in Figure 2c , treatment of cells with 100 nM wortmannin modestly reduced the late phase of PKCε activity. In these cells, 100 nM wortmannin effectively blocks PDGF-dependent accumulation of PI 3-kinase products [14] . These findings indicate that PI 3-kinase does not play a crucial role in activation of PKCε, although it does seem to enhance activation at the late time points (Figure 2c ).
The kinetics of PDGF-dependent activation of the other PKC family members was also determined. The cPKCs were immunoprecipitated using an antibody that recognizes all members of the cPKC subfamily and the activity was determined using an in vitro kinase assay. Like PKCε, at least some cPKC subfamily members were transiently activated within 10 minutes of exposure to PDGF, and a prolonged phase of increased activity was detected 4-8 hours later (data not shown). Thus, multiple PKC family members, representing at least two of the PKC subfamilies, were activated at two distinct time points in PDGF stimulated HepG2 cells.
The late phase of PKC activity is required for PDGFdependent DNA synthesis
The data presented thus far demonstrate that the DNA synthesis response could be rescued when DAG was added 7 hours after PDGF stimulation in HepG2 cells expressing F5 βPDGFRs (Figure 1a ), and that PKCε was activated 5-9 hours after exposure to PDGF in HepG2 cells expressing wild-type βPDGFRs (Figure 2a ). This suggests that the late phase of PKC activity is involved in PDGF-dependent DNA synthesis. If this is the case, then DAG should be activating PKCs when it is added to the rescue assay described in Figure 1 . To test this idea, PKCε activity was determined under the conditions used in the DAG rescue assay. PDGF-dependent activation of PKCε. Quiescent HepG2 cells expressing (a,c) wild-type (WT), (b) F5 or (d) Y40/51 βPDGFRs were stimulated with 50 ng/ml PDGF for the indicated period of time. Cells were lysed, PKCε was immunoprecipitated and subjected to an in vitro kinase assay using a PKC-selective synthetic peptide (Ac-FKKSFKL-NH 2 in the single-letter amino acid code; Ac, acetyl) as a substrate as previously described [25] . PKCε activity was assayed with or without 150 µg phosphatidylserine (PS) and 5 µg DAG; the presence of the lipids did not influence the kinase activity of PKCε, and the data presented here were obtained in the absence of PS and DAG. In (c), cells were treated with 100 nM wortmannin 2 h 50 min after PDGF stimulation and 50 nM wortmannin was added again at the 4 h 50 min time point. These times were chosen to accommodate the half-life of wortmannin (2 h) as well as the timing of the second wave of accumulation of PI 3-kinase products (3-7 h) [2] . The reactions were terminated and then spotted onto P81 paper and washed, and the amount of radioactivity was determined by scintillation counting. The data are presented as the fold increase compared with buffer-treated control cells. The average of three experiments is shown, and the error bars represents standard error of the mean. The bottom portion of each panel is a western blot of the PKCε immunoprecipitate that was used in the kinase assay.
This finding suggests that DAG mediates PDGF-dependent DNA synthesis via activation of PKCs, including PKCε.
An additional approach to test whether, and when, PKCs are required for PDGF-dependent DNA synthesis involved the use of PKC inhibitors. The three PKC inhibitors chosen inhibit DAG-responsive PKCs but not the other family members. Each of these inhibitors was tested for their effect on PDGF-dependent DNA synthesis in cells expressing wild-type βPDGFs. Figure 4 shows that PDGF-dependent DNA synthesis was attenuated by 60-80% by each of three PKC inhibitors. This effect was observed when the inhibitors were added either 10 minutes before or 7 hours after PDGF. Inhibition of the DNA-synthesis response by adding the inhibitors late indicated that there is a late requirement for PKC activity. It is likely that the cells pretreated with the inhibitor failed to respond to PDGF because the inhibitors have a long enough half-life to block the late phase of PKC activity. However, this particular experimental approach did not rule out the possibility that the initial activation of PKC is required for subsequent DNA synthesis.
To explore whether the early burst of PKC activity is required for DNA synthesis we used an inhibitor-washout strategy. At least one of these inhibitors is known to be reversible [15] . Figure 4 shows that removing the PKC inhibitors after 1 hour largely reversed the inhibitory effects on PDGF-dependent DNA synthesis. This was true for two of the three PKC inhibitors, whereas the 1-O-hexadecyl-2-O-acetyl-sn-glycerol-treated culture did not fully recover, perhaps due to incomplete removal of the inhibitor. These results indicate that the early phase of PKC activity is dispensable for the entry into S phase, whereas the late phase of PKC activity was essential for the PDGF-dependent mitogenic response.
PKCε ε does not make a major contribution to the PI 3-kinase-dependent mitogenic signaling
We have previously found that PI 3-kinase products accumulate in PDGF-stimulated cells at two times, immediately after stimulation and then 3-7 hours later; the latter time at least in part overlaps with the second phase of PKCε activity. Furthermore, the late wave of PI 3-kinase activity was required for PDGF-dependent DNA synthesis [4] . These findings, together with the observation that the late wave of PKCε activity was contributing to S phase entry (Figure 4) , suggested that PKCε may be an essential DAG activates PKCε in the conditions used in the DAG rescue assay. Quiescent HepG2 cells expressing F5 βPDGFRs were stimulated with 50 ng/ml PDGF, and 100 µg/ml DAG was added either simultaneously with PDGF or 7 h later. Cells were lysed 10 min after the addition of DAG and PKCε immunoprecipitated. PKCε activity was determined as described in the legend of Figure 2 . The data presented are the fold increase compared with buffer-treated control cells. The average of three independent experiments is shown, and the error bars represents standard error of the mean. These findings indicate that PKCε was activated by the exogenously added DAG at either time point. Note that cells were driven into S phase only when DAG was added at the late time point (Figure 1a ).
Figure 4
PKC inhibitors block PDGF-induced DNA synthesis. Quiescent HepG2 cells expressing wild-type βPDGFRs were stimulated with 10% FBS or 50 ng/ml PDGF or exposed to buffer in the control group (left panel). The samples in the right panel were treated in one of the three ways. In the left group, the cells were pretreated for 10 min with 20 µM 1-O-hexadecyl-2-O-acetyl-sn-glycerol, 50 µM calphostin C, or 20 nM bisindolylmaleimide I, then 50 ng/ml PDGF was added. In the middle group, PDGF was added first and inhibitors were added 7 h later. In the right group, inhibitors were added 10 min before PDGF and removed by washing 1 h after PDGF. The incubation was continued in the media containing 50 ng/ml PDGF or buffer. After a total of 18 h, the cells were pulsed with component of the PI 3-kinase-dependent mitogenic pathway. To investigate this possibility, we tested whether blocking PKCs would prevent PI 3-kinasedependent entry into S phase. The first approach was to use the Y40/51 receptor, which activates the PI 3-kinase pathway, but not the PLCγ pathway. As predicted, this receptor was able to trigger activation of PKCε (Figure 2d ), yet two different PKC inhibitors had little effect on PDGF-dependent DNA synthesis in cells expressing this receptor (Figure 5a ). The second approach was to use the PI 3-kinase lipid rescue assay [4] , which is similar to the DAG rescue assay described in Figure 1 , except PI 3-kinase lipid products are used instead of DAG. As with the first approach, we found that the PKC inhibitors were not able to potently inhibit DNA synthesis (Figure 5b) . Finally, Figure 5c shows that the PKC inhibitors were specific, as they were unable to block PI 3-kinase-dependent phosphorylation of Akt. We conclude that, although engagement of PI 3-kinase does activate PKCε, it does not appear to be making an essential contribution to the PI 3-kinase-dependent mitogenic pathway.
Discussion
In the continuous presence of PDGF, PKCε activity increased quickly (at 10 minutes) then receded and gradually increased a second time for a much longer duration (5-9 hours; Figure 2a ). These observations raise the question of what is regulating the activity of PKCs. There are two aspects of PKC regulation, lipid co-factors and phosphorylation of PKCs by other kinases such as 3-phosphoinositide-dependent protein kinase (PDK-1) [16] . Both DAG and PtdIns-3,4,5-P 3 have been shown to contribute to activation of PKCε [10] . Changes in the level of DAG do not adequately explain the changes in PKCε activity. We and others [17] have found that the level of DAG increases and remains elevated in PDGF-stimulated cells, but the activity of PKCε rises and falls within this time interval. Although it is likely that the increase in DAG is contributing to PKCε activation, it does not fully explain how PKCε is activated. Similarly, changes in PtdIns-3,4,5-P 3 levels did not correspond to the observed fluctuation in PKCε activity, and blocking PI 3-kinase activity did not eliminate PDGF-dependent activation of PKCε (Figure 2c) . Thus, neither of the lipid co-factors appear fully responsible for the changes in PKCε activity. Perhaps the input from other kinases, such as PDK-1, make an important contribution to PKCε activation.
PLCγ could be participating in the regulation of PKCε activity, but perhaps not through its lipase activity. Microinjection of catalytic-defective PLCγ into NIH 3T3 cells only partially inhibits DNA synthesis, whereas complete inhibition is obtained by microinjection of antibodies that interact with the PLCγ noncatalytic domain [6] . This observation suggests that the noncatalytic domain of PLCγ is critical for PLCγ mitogenic signaling. PLCγ activity persisted up to two hours after PDGF stimulation, but tyrosine phosphorylation and association with the βPDGFR lasts for at least 8 hours in HepG2 cells (data not shown). This observation raises a question about the role of PLCγ in the late activation of PKCs. Perhaps PLCγ participates in the induction of the late phase of PKCε activity, but not through its enzymatic activity. The role of PLCγ in the late phase of PKC activity is being further investigated.
Our findings have begun to address the importance of cross-talk between the PI 3-kinase and PLCγ pathways. At the level of enzyme activation, there are several ways in which PI 3-kinase contributes to PKC-dependent activation. In certain settings, PI 3-kinase lipids recruit PLCγ to the membrane and promote its activation [18] [19] [20] . Similarly, PI 3-kinase products recruit PDK-1 to the membrane, and PDK-1 phosphorylates some PKC family members on the activation loop [16] . PI 3-kinase products also act as lipid co-factors for certain PKCs [12] . Despite the ability of the PI 3-kinase pathway to promote activation of PKCε, this does not translate to cellular responses such as cell cycle progression. Blocking conventional and novel PKCs failed to markedly attenuate the PI3K-dependent entry into S phase ( Figure 5 ). These studies indicate that neither PKCε nor other DAG-dependent PKCs serves as a convergence point for PI 3-kinase in the PKCdependent mitogenic cascades. Although our studies do not rule out the existence of cross-talk between the PI 3-kinase and PLCγ pathways during mitogenic signaling, we could not find a step that requires such an interaction. Perhaps the ability of these two signaling systems to interface is more important in other cellular responses.
We found that the first, transient burst of PKC activity is dispensable for PDGF-dependent DNA synthesis and that PKCs make an important contribution at the latter time points. Consequently, the PDGF-dependent transition into S phase appears to proceed unimpeded when at least some of the PKCs are not activated. It is possible that the early PKC requirement [21, 22] is compensated for by one of the numerous other signaling cascades initiated by PDGF. In contrast, further progression into the S phase requires PKC activity. Perhaps the requirement for PKCs relates to its ability to modulate levels of the cyclin-dependent kinase inhibitor p27 Kip1 and/or phosphorylate retinoblastoma, as has been previously reported [23, 24] . Our future studies will be focused on further investigation of these questions.
Conclusions
We conclude that, in response to PDGF, PKCε and at least some of the conventional PKC family members are activated at two distinct time points. The second phase of PKCs activity is required for S phase entry, but the first phase is dispensable. In addition, our studies indicate that PKCε can be activated by either the PI 3-kinase-dependent or the DAG-dependent pathway, but PKCε does not make a major contribution to the PI 3-kinase-dependent mitogenic signaling.
Materials and methods
HepG2 cells expressing wild-type or F5 βPDGFRs were previously described [7] . Cells were maintained in Dulbecco's modified Eagles's medium (DMEM) supplemented with 10% fetal bovine serum (FBS). Polyclonal antibodies against PKCε were obtained from Santa Cruz. For western blots, antibodies were used at a 1:500 dilution. Peroxidase-conjugated goat anti-rabbit and goat anti-mouse antibodies were purchased from Calbiochem and were used at a 1:5000 dilution. Calphostin C and bisindolylmaleimide I were purchased from Calbiochem, 1-O-Hexadecyl-2-O-acetyl-sn-glycerol was purchased from BioMol, PDGF-BB was generously provided by Amgen, 1,2-di-octanoyl-sn-glycerol (DAG) was obtained from Avanti Polar Lipids, the PKC-selective synthetic peptide (Ac-FKKSFKL-NH 2 ) used in PKC kinase assay was described in [25] , wortmannin was purchased from Sigma, and PtdIns-3,4-P 2 and PtdIns-3,4,5-P 3 were obtained from Echelon Research Laboratories.
[ 3 H]thymidine incorporation
[ 3 H]thymidine incorporation was done as previously described [7] with some modifications. HepG2 cells expressing F5 or wild-type βPDGFRs were plated in 24-well plates at a density of 5 × 10 4 cells per well in DMEM plus 10% FBS for 24 h. The cells were washed twice with PBS and DMEM supplemented with 0.2% FBS was added for 48 h. The cells were then stimulated with 50 ng/ml PDGF or 10% FBS. PDGF buffer (10 mM acetic acid and 2 mg/ml bovine serum albumin) or dimethylsulfoxide (DMSO) was added to the media of control cells. DAG or PKC inhibitors (stock solutions prepared in DMSO) were added at the indicated times and concentrations. The cultures were incubated for 18 h and then pulsed with 0.8 µCi/ml [ 3 H]thymidine in DMEM plus 5% FBS for 4 h. Cells were washed first with ice-cold PBS, then with 5% trichloroacetic acid and lysed in 0.25 N NaOH. Lysates were transferred into scintillation vials containing 50 µl of 6 N HCl and 4 ml of scintillation cocktail (ICN). The incorporated radioactivity was determined by liquid scintillation counting.
Immunoprecipitation
Immunoprecipitation of βPDGFRs was done as previously described [26] . Subconfluent HepG2 cells expressing wild-type βPDGFRs were serum starved in DMEM plus 0.2% FBS at 37°C in 5% CO 2 for 30 h. PDGF or PDGF buffer were added into the media and incubation was continued for the indicated time. Cells were washed twice with ice-cold wash buffer (20 mM HEPES pH 7.4, 150 mM NaCl) and lysed in lysis buffer (10 mM Tris-HCl pH 7.4, 5 mM EDTA, 150 mM NaCl, 50 mM NaF, 1% Triton X-100, 20 µg/ml aprotinin, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium orthovanadate and 10% glycerol). The lysates were centrifuged at 13,000 × g for 15 min at 4°C and the protein concentration of the clarified lysates was determined using the bicinchoninic acid protein assay (Pierce).
Antibodies against PKCε or cPKCs were added to 1 mg of cell lysates. The immune complexes were bound to formalin-fixed membranes of Staphylococcus aureus, spun through lysis buffer plus 10% sucrose, washed twice with wash buffer (10 mM PIPES pH 7.0, 100 mM NaCl, 20 µg/ml aprotinin) plus 0.5% Nonidet P-40 plus 0.5 M LiCl, twice with wash buffer plus 0.5 M NaCl and twice with wash buffer. Immunoprecipitates were resuspended in 30 µl of wash buffer and used immediately or stored at -70°C.
DAG assay
HepG2 cells expressing wild-type βPDGFRs were plated in 100 mm dishes and incubated at 37°C for 24 h and serum-starved in DMEM plus 0.2% FBS. After 30 h the cells were stimulated with PDGF for the indicated period of time. The incubation was terminated by removing the medium and adding 2 ml ice-cold methanol/0.1 N HCl (1:1). The cells were scraped and lipids were extracted with 1 ml chloroform. The amount of DAG in the chloroform fraction was measured by using a DAG assay kit (Amersham). A 200 µl aliquot of the chloroform fraction was used per reaction. DAG in the sample was converted to phosphatidic acid using bacterial DAG kinase in the presence of [γ-32 P]ATP. The resulting [ 32 P]phosphatidic acid was separated by thin-layer chromatography on Silicia gel 60 A plates (Whatman). The amount of radiolabeled phosphatidic acid was quantitated using a PhosphoImager (BioRad).
PKC kinase assay
The PKC kinase assays were performed as described [25] with some modifications. Briefly, PKC immunoprecipitate (100% of a subconfluent 100 mm dish) was incubated with 150 nM of PKC-selective synthetic peptide (Ac-FKKSFKL-NH 2 ) in kinase buffer (10 mM HEPES, 1 mM DTT, 5 µCi [γ-32 P]ATP, 10 µM ATP, 10 mM MnCl 2 ) in the presence or absence of 150 µM phosphatidylserine and 5 µM DAG for 10 min at 25°C in a final volume of 80 µM. The reaction was stopped by centrifugation at 3000 × g for 5 min, which separated the immobilized PKC immunoprecipitates from the soluble substrate. The supernatant from each of the samples was spotted onto P81 ion-exchange chromatography paper, washed 4 times with 1% phosphoric acid and the incorporation of 32 P into peptide was detected by liquid scintillation counting.
Lipid rescue assay
The PI 3-kinase lipid rescue assay was performed as previously described [4] . HepG2 cells expressing F5 βPDGFRs were plated in DMEM supplemented with 10% FBS at a density of 4 × 10 4 cells per well in 24-well plate for 24 h. The cells were washed twice with 1 ml PBS and incubated in DMEM supplemented with 0.2% FBS for 48 h. The cells were stimulated with 50 ng/ml PDGF, PDGF buffer or 10% FBS. Some of the cultures were treated with either calphostin C (50 nM) or bisindolylmaleimide I (20 nM) at 5 h 50 min post PDGF stimulation. Some of the cultures were also given 25 µM each PtdIns-3,4-P 2 and PtdIns-3,4,5-P 3 at 6 h post PDGF. For these samples, the stimulation medium was removed and replaced with permeabilization buffer (100 µl PBS containing 0.05 mg/ml saponin) as well as the lipids. The permeabilization and lipid administration was performed at 25°C for 10 min. For these samples, the stimulation media was reserved during the lipid addition and added back to their respective cultures after lipid administration. The incubation was continued for 12 h and after that cells were pulsed with [ 3 H]thymidine. The incorporated [ 3 H]thymidine was measured as described above.
Western blotting analysis
Immunoprecipitates were boiled at 95°C in SDS-PAGE buffer (200 mM Tris-HCl pH 6.8, 10 mM EDTA, 4% SDS, 5.6 M β-mercaptoethanol, 20% glycerol, 0.2% bromophenol blue) for 4 min, resolved on a 10% SDS-PAGE gel and transferred onto Immobilon (Millipore). Membranes were blocked with TBST (10 mM Tris base pH 8.0; 150 mM NaCl, 0.2% Tween-20) plus 5% nonfat dry milk for 1 h, probed with primary antibodies, washed with rinse buffer (10 mM Tris base pH 7.5, 150 mM NaCl) and probed with peroxidase-conjugated secondary antibodies. Proteins were detected using enhanced chemiluminescence (Amersham Pharmacia Biotech).
